The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Infusion of the β-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats*
Abstract
OBJECTIVE: Since beta-blocker therapy is known to be effective in patients with an injured heart, such as infarction, we designed the present study to examine the protective effects of infusion of the beta1-selective blocker esmolol on myocardial function in peritonitis-induced septic rats using an isolated working heart preparation. DESIGN: Randomized animal study. SETTING: University research laboratory. SUBJECTS: Thirty-one rats treated with cecal ligation and perforation to evoke peritonitis. INTERVENTIONS: After cecal ligation and perforation, rats were randomly allocated to the control group (normal saline 2 mL/hr, n = 11), low-dose esmolol group (10 mg/kg/hr, n = 10), or high-dose esmolol group (20 mg/kg/hr, n = 10). After obtaining blood samples for measurement of arterial lactate and tumor necrosis factor-alpha at 24 hrs, we assessed cardiac output, myocardial oxygen consumption, and cardiac efficiency (cardiac output x peak systolic pressure/myocardial oxygen consumption) at various preloads in an isolated perfused heart preparation. MEASUREMENTS AND MAIN RESULTS: Esmolol infusion did not cause an elevation of arterial lactate levels but reduced tumor necrosis factor-alpha concentrations vs. the control group (p < .05). Both cardiac output and cardiac efficiency in the esmolol-treated rats were significantly higher throughout the study periods vs. the control group (p < .05). CONCLUSIONS: Esmolol infusion in sepsis improved oxygen utilization of myocardium and preserved myocardial function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Early goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., & Tomlanovich, M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010307 · Cited by 10,743
Cited by
Merx, M. W., & Weber, C. (2007) · Circulation · doi:10.1161/circulationaha.106.678359 · Cited by 603
Sepsis-induced myocardial dysfunction: pathophysiology and management
Kakihana, Y., Ito, T., Nakahara, M., Yamaguchi, K., & Yasuda, T. (2016) · Journal of Intensive Care · doi:10.1186/s40560-016-0148-1 · Cited by 544
Sympathetic Overstimulation During Critical Illness: Adverse Effects of Adrenergic Stress
Dünser, M. W., & Hasibeder, W. R. (2009) · Journal of Intensive Care Medicine · doi:10.1177/0885066609340519 · Cited by 488
Sepsis-Induced Cardiomyopathy: a Comprehensive Review
L’Heureux, M., Sternberg, M., Brath, L., Turlington, J., & Kashiouris, M. G. (2020) · Current Cardiology Reports · doi:10.1007/s11886-020-01277-2 · Cited by 383
J. Romero-Bermejo, F., Ruiz-Bailen, M., Gil-Cebrian, J., & J. Huertos-Ranchal, M. (2011) · Current Cardiology Reviews · doi:10.2174/157340311798220494 · Cited by 287
Metadata
- Authors
- Suzuki, T., Morisaki, H., Serita, R., Yamamoto, M., Kotake, Y., Ishizaka, A., & Takeda, J.
- Venue
- Critical Care Medicine
- Published
- 2005-10
- Volume
- 33
- Issue
- 10
- Pages
- 2294-2301
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2008995419
- Cited by
- 166
- References
- 1
- FWCI
- 4.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Infusion of the β-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats*. https://app.cochat.ai/papers/10.1097/01.ccm.0000182796.11329.3b
- The paper
- Suzuki, T., Morisaki, H., Serita, R., Yamamoto, M., Kotake, Y., Ishizaka, A., & Takeda, J. (2005). Infusion of the β-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats*. Critical Care Medicine. https://doi.org/10.1097/01.ccm.0000182796.11329.3b
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.